Internal Medicine NewsComplication rates decline among diabetes patientsApril 16, 2014DiabetesEndocrinologyCardiology
Internal Medicine NewsFDA approves GLP-1 receptor agonist albiglutide for type 2 diabetesApril 15, 2014DiabetesEndocrinology
Internal Medicine NewsIncreasing maternal BMI raises fetal, infant death riskApril 15, 2014ObesityWomen's HealthEndocrinology
Internal Medicine NewsDiabetes prevalence increases, but so does diabetes controlApril 14, 2014DiabetesObesityEndocrinology
Internal Medicine NewsACC/AHA cardiovascular risk equations get a thumbs-upApril 14, 2014ObesityCardiologyEndocrinology
Internal Medicine NewsNewcomer misses noninferiority mark against established GLP-1 receptor agonist April 10, 2014DiabetesEndocrinology
Internal Medicine NewsYounger men with goiter at higher risk for thyroid cancersApril 10, 2014EndocrinologyOncology
Internal Medicine NewsWeekly exenatide shows long-term efficacy in type 2 diabetesApril 9, 2014DiabetesEndocrinology
Internal Medicine NewsVIDEO: PCSK9 inhibitors placed in perspectiveApril 7, 2014CardiologyEndocrinologyObesity
Internal Medicine NewsFDA panel backs approval of inhaled insulin for type 1 and 2 diabetesApril 2, 2014PulmonologyDiabetesEndocrinology
Internal Medicine NewsBariatric surgery’s benefit persists in type 2 diabetes April 1, 2014DiabetesObesityEndocrinology
Internal Medicine NewsEvolocumab betters ezetimibe for lowering LDL in statin-intolerant patientsMarch 31, 2014CardiologyEndocrinologyObesity
Internal Medicine NewsNo improvements in left ventricular function with metformin after myocardial infarctionMarch 31, 2014CardiologyEndocrinology
Internal Medicine News'Revolutionary' LDL lowering shown in evolocumab phase III trialsMarch 30, 2014CardiologyEndocrinologyObesity
Internal Medicine NewsAleglitazar failed to reduce cardiovascular events in type 2 diabetesMarch 30, 2014DiabetesCardiologyEndocrinology
